Squarepoint
MBOT icon

Squarepoint’s Microbot Medical MBOT Stock Holding History

Squarepoint’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
125,593
+101,067
+412% +$226K ﹤0.01% 3697
2025
Q4 		$49.1K Buy
24,526
+12,419
+103% +$29.4K ﹤0.01% 4132
2025
Q3 		$36.9K Buy
+12,107
New +$37.8K ﹤0.01% 4253
2025
Q2 		– Sell
-14,616
Closed -$22.1K – 4827
2025
Q1 		$22.1K Buy
+14,616
New +$25.8K ﹤0.01% 4430
2017
Q4 		– Sell
-2,593
Closed -$46K – 2239
2017
Q3 		$46K Buy
+2,593
New +$45.7K ﹤0.01% 1567

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Squarepoint's MBOT Position: Q1 2026 in Review

Squarepoint increased its Microbot Medical (MBOT) stake by 412% in Q1 2026, buying an estimated $226K and bringing the position to 125,593 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Squarepoint first reported a position in MBOT in Q3 2017 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Squarepoint held 125,593 shares of Microbot Medical worth $303K as of Q1 2026.
  • Squarepoint bought 101,067 Microbot Medical shares in Q1 2026, an estimated $226K.
  • Microbot Medical made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3697 holding.
  • Squarepoint first reported a position in Microbot Medical in Q3 2017 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.